Why are you reporting this TALK?
BIMIKIZUMAB and SpA
Leonard Calabresemailview.bulletinhealthcare.com
to learn moreJanuary 18, 2023
15 hr
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
BIMIKIZUMAB and SpA